Skip to content
Business · World
AstraZeneca halts late-stage lung cancer drug trial
2 sourcesFirst reported 2 hours agoUpdated 1 hour ago
Left 50%
Center 50%
1 left-leaning1 center
Left-leaning outlets dominate coverage at 50%. This often signals the story aligns with progressive priorities, or that right-leaning media is downplaying it. The 0% right-leaning coverage may offer a contrasting angle worth reading.
Who reported first
SigmaliveFirst
Dialogos+28m
All coverage
